Connor, Clark & Lunn Investment Management (CC&L)
CPRX

Connor, Clark & Lunn Investment Management (CC&L)’s Catalyst Pharmaceutical CPRX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-95,005
Closed -$2.06M – 1528
2025
Q2 		$2.06M Sell
95,005
-66,267
-41% -$1.56M 0.01% 852
2025
Q1 		$3.91M Buy
+161,272
New +$3.63M 0.02% 564
2024
Q4 		– Sell
-10,057
Closed -$200K – 1435
2024
Q3 		$200K Buy
+10,057
New +$186K ﹤0.01% 1326
2023
Q2 		– Sell
-192,926
Closed -$3.2M – 1342
2023
Q1 		$3.2M Buy
192,926
+163,060
+546% +$2.69M 0.02% 454
2022
Q4 		$556K Sell
29,866
-73,142
-71% -$1.13M ﹤0.01% 840
2022
Q3 		$1.32M Buy
+103,008
New +$1.22M 0.01% 591
2022
Q2 		– Sell
-24,431
Closed -$203K – 1068
2022
Q1 		$203K Sell
24,431
-11,840
-33% -$83.7K ﹤0.01% 943
2021
Q4 		$246K Buy
+36,271
New +$239K ﹤0.01% 928
2020
Q2 		– Sell
-49,050
Closed -$189K – 1043
2020
Q1 		$189K Buy
+49,050
New +$201K ﹤0.01% 873
2019
Q3 		– Sell
-14,332
Closed -$55K – 974
2019
Q2 		$55K Buy
+14,332
New +$61.9K ﹤0.01% 967
2019
Q1 		– Sell
-36,700
Closed -$70K – 932
2018
Q4 		$70K Buy
36,700
+5,688
+18% +$16.3K ﹤0.01% 914
2018
Q3 		$117K Buy
31,012
+6,012
+24% +$18.8K ﹤0.01% 881
2018
Q2 		$78K Buy
+25,000
New +$75.8K ﹤0.01% 1004

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CPRX Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Catalyst Pharmaceutical (CPRX) in Q3 2025, closing a stake of 95,005 shares — an estimated $2.06M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CPRX in Q2 2018 and held it in 13 quarters. The position peaked at $3.91M in Q1 2025. 360 funds tracked by Wall St. Rank hold CPRX as of Q3 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Catalyst Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 95,005 Catalyst Pharmaceutical shares in Q3 2025, an estimated $2.06M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Catalyst Pharmaceutical in Q2 2018 and held it in 13 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Catalyst Pharmaceutical position peaked at $3.91M in Q1 2025.
  • 360 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.